Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neighbourly Pharmacy Inc T.NBLY.R


Primary Symbol: T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or Rubicon Pharmacies. The Company owns and operates approximately 287 locations across seven provinces and one territory, a coast-to-coast footprint that provides scale and diversification. The Company’s pharmacies provide accessible healthcare with a personal touch. The Company also owns British Columbia-based pharmacies.


TSX:NBLY - Post by User

Post by incomedreamer11on Aug 03, 2021 3:22pm
153 Views
Post# 33643195

for your interest

for your interest

Neighbourly Pharmacy Inc. (NBLY.TO), a network of community pharmacies, on Tuesday reported a net loss of $76.9 million or $7.50 per share for its fiscal first quarter ended June 19, compared with a loss of just under $5 million or $10.80 per share in the same period a year ago.

The company attributed the bigger loss to $74.1 million in one-time and non-cash items related to the conversion of its preferred shares and warrants into common shares concurrent with its IPO in late May.

The company recorded revenue of $85.3 million in its fiscal first quarter 2022, up 55.2% from $55.0 million a year ago on the back of 40 pharmacies added to the network over the period. Same-store sales growth rose to 8.2% from 0.1%.

Adjusted EBITDA came in at $10.1 million, up from $6.6 million in the year-ago quarter, mainly due to the incremental profitability of pharmacies added to the company's network.

Neighbourly Pharmacy intends to further expand its network over the year ahead, citing more than 3,600 independent pharmacies across Canada that meet its acquisition criteria

<< Previous
Bullboard Posts
Next >>